They found that the polysaccharide could suppress clinical manifestations of colitis by down-regulating the markers of oxidative stress such as nitric oxide (NO) and the pro-inflammatory cytokines, including IL-1β, TNF-α, and IL-6. The gene discussed is IL6; the disease is colitis.